Ignite Creation Date:
2024-05-06 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 2:17 PM
Study NCT ID:
NCT05118386
Status:
COMPLETED
Last Update Posted:
2024-05-20
First Post:
2021-10-06
Brief Title:
Safety Tolerability and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults
Sponsor:
Bill Melinda Gates Medical Research Institute
Organization:
Bill Melinda Gates Medical Research Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2021-10-06
First Submit QC Date:
November 11 2021
Study First Post Date:
2021-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2024-05-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-12-01
Last Update Post Date:
2024-05-20
Last Update Post Date Type:
ACTUAL